Financial report outlook | Market expectations Accenture Plc Class A (ACN.US) Q4 revenue increased by 2.2% year-on-year, with the AI field becoming a key factor.
Market expects that Accenture (ACN.US) will have a Q4 revenue of $16.33 billion, an increase of 2.2% from the same period last year; expected earnings per share of $2.77, an increase of 2.2% year-on-year.
Accenture Plc Class A (ACN.US) will release its fourth-quarter performance for 2024 on September 26th. Market expectations are for revenue of $16.33 billion, a 2.2% increase from the same period last year; expected earnings per share are $2.77, a 2.2% increase year-on-year.
In the past four quarters, the company's earnings per share have surpassed general expectations three times.
Whether the company can continue its strong performance in the field of artificial intelligence will impact this quarter's performance.
In the third-quarter financial report, Accenture Plc Class A saw a surge in new bookings to $21.1 billion, a significant 22% increase from the same period last year. Additionally, the company's new bookings in the generative AI field broke the $1 billion mark in the third quarter.
Related Articles

Standard Chartered (02888) announces third quarter results with a net profit attributable to the parent company's shareholders of $1.3 billion, a 13% year-on-year increase.

Polar Rabbit (01519) Officially Opens the World's Largest Self-built Logistics Hub, Fully Guaranteeing the Logistics Peak of "Double 11"

HK Stock Market Move | Pharmaron Beijing (03759) surged more than 4%, with a 42.5% year-on-year increase in net profit attributable to shareholders in the third quarter. The company also raised its full-year revenue growth guidance.
Standard Chartered (02888) announces third quarter results with a net profit attributable to the parent company's shareholders of $1.3 billion, a 13% year-on-year increase.

Polar Rabbit (01519) Officially Opens the World's Largest Self-built Logistics Hub, Fully Guaranteeing the Logistics Peak of "Double 11"

HK Stock Market Move | Pharmaron Beijing (03759) surged more than 4%, with a 42.5% year-on-year increase in net profit attributable to shareholders in the third quarter. The company also raised its full-year revenue growth guidance.

RECOMMEND

The Capital Conundrum of Dongpeng Beverage: Distributing ¥5.4 Billion in Profits While Raising Capital in Hong Kong with Over ¥10 Billion Cash on Hand | IPO Watch
29/10/2025

Totaling $550 Billion: Japan’s U.S. Investment Project List Revealed, Largest Projects Near $100 Billion, U.S. Stocks in Related Sectors Rally
29/10/2025

Humanoid Robot Theme Maintains Momentum — Cathie Wood Backs It as One of AI’s Largest Opportunities
29/10/2025


